生意详情
Nex8 Labs is a UK-registered (Company No. 16603315) direct-to-consumer men's skincare brand, launched in December 2025 and fully operational via Shopify at www.nex8labs.com. The brand is pre-revenue and being sold as a built, investment-ready asset rather than a trading business.
The brand sells The Protocol System, a three-product peptide skincare range for men comprising an aloe cellular cleanser, multi-peptide moisturiser, and copper peptide night serum. Products are UK-manufactured, Vegan Society certified, and built around clinically-studied ingredients including SYN-AKE, Matrixyl 3000, SNAP-8, and GHK-Cu copper peptides. The brand received genuine press coverage in Men's Health prior to launch.
Everything a buyer needs to begin trading immediately is in place: live Shopify store with native subscription functionality, Klaviyo email integration, active Meta advertising infrastructure, fulfillment partnership with E-PickPack Ltd, Vegan Society certification, brand assets, whitepaper, and documented supplier relationships with UK manufacturer Cosmiko.
The brand occupies a genuine white space as the UK's first men's skincare brand exclusively focused on peptide technology, targeting professional men aged 30 to 55. A detailed growth roadmap exists covering UK scaling, European expansion, and a targeted exit valuation of £10 to 20M.
The right buyer is someone with marketing budget and the appetite to deploy it behind a brand that is fully built and strategically positioned, but has not yet been taken to market at scale.